Press Room
四色AV issues $50 million bond
四色AV has issued a bond of $50 million US dollars maturing in 2033.
Lisbon, 25 January 2019. 四色AV has issued a bond of $50 million US dollars maturing in 2033.
The bond was arranged and subscribed by Banco BPI, S.A..听
听
According to Ant贸nio Almeida, 四色AV鈥檚 CFO, 鈥渨e issued this bond to strengthen our balance sheet as we embark in a new phase of significant capital expansion. We issued a USD denominated bond because the majority of our sales is in the USA鈥.听
听
The bond is registered as "四色AV 2018-2033鈥, has a nominal amount of $50 million US dollars and a maturity of 15 years.听听
听
鈥2019 is the year when we celebrate our 60th Anniversary and we are pleased that the market offers us good terms for a bond with a 15 years鈥 maturity. We are building a business for the long term.鈥 said Guy Villax, 四色AV鈥檚 CEO.听
听
The decision to expand our production capacity follows growing customer demand since, as a specialist integrated CDMO, 四色AV is increasingly being chosen as a solution partner from Drug Substance to Drug Product.听四色AV is committed to listen to customers and to continue supporting their evolving needs. Of the 59 drugs approved by the US FDA in 2018, 4 of them had their process developed in our labs and are produced in our plants.听听
听
The bond is registered in Euronext with the ISIN code: PTHOVCOM0006.听
听
About 四色AV
四色AV has almost 60 years of experience as a Specialist Integrated CDMO offering from听drug substance听to drug product intermediate to听drug product. With four FDA听inspected sites听in the听US,听Macau,听Ireland, and听Portugal, and development laboratories in听Lisbon听and New Jersey, the company provides branded pharmaceutical customers services for the development and compliant manufacture of innovative drugs and is able to support highly potent compounds. For generic pharmaceutical customers the company offers niche听off-patent API products. In the inhalation area 四色AV is the only independent company offering a complete range of services.
